⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9686981 | 1.00 | — | — | |
| SCHEMBL14972809 | 0.98 | NAMPT (0.47) | — | |
| SCHEMBL28943338 | 0.98 | NAMPT (0.47) | — | |
| SCHEMBL29597368 | 0.98 | NAMPT (0.47) | — | |
| SCHEMBL3972493 | 0.86 | — | — | |
| SCHEMBL2834476 | 0.86 | — | — | |
| SCHEMBL9943877 | 0.86 | — | — | |
| SCHEMBL1311913 | 0.84 | — | — | |
| SCHEMBL980488 | 0.77 | — | — | |
| SCHEMBL30881494 | 0.76 | NAMPT (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114599657-B | Crystalline forms of CFTR modulators | 弗特克斯药品有限公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-114555556-B | Process for preparing CFTR modulators | 弗特克斯药品有限公司 | 2024-03-29 | — | — | CN | disclosed |
| EP-4259139-A1 | METHODS OF TREATMENT FOR CYSTIC FIBROSIS | Vertex Pharmaceuticals Incorporated (US) | 2023-10-18 | — | — | EP | disclosed |
| CN-116322676-A | Crystalline forms of CFTR modulators | 弗特克斯药品有限公司 | 2023-06-23 | — | — | CN | disclosed |
| WO-2022125826-A1 | METHODS OF TREATMENT FOR CYSTIC FIBROSIS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-06-16 | — | — | WO | disclosed |
| CN-114599657-A | Crystalline forms of a CFTR modulator | 弗特克斯药品有限公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-114555556-A | Methods of making CFTR modulators | 弗特克斯药品有限公司 | 2022-05-27 | — | — | CN | disclosed |
| EP-0307078-B1 | QUINOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) | 1992-08-26 | — | — | EP | disclosed |
| US-5051508-A | Antisecretory agents and enzyme inhibitors as antiulcer agents | SMITHKLINE BECKMAN INTERCREDIT B.V. (NL) | 1991-09-24 | — | — | US | disclosed |
| EP-0307078-A1 | Quinoline derivatives, process for their preparation and pharmaceutical compositions containing them | SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) | 1989-03-15 | — | — | EP | disclosed |